A settlement has been made on the case involving the state of Utah and Eli Lilly that results in an award of $24 million. The case involved the pharmaceutical drug, Zyprexa, which is said to be an anti-psychotic drug. Utah-based attorney, Mr. Mark Shurtleff stated that, “the victims of this drug are the ones who can least afford any type of healthcare”. January becomes an opportune time for the settlement money to be collected due to the fact that state lawmakers have a possibility of facing a $850 million shortfall.
Source: News Release From Attorney Generals’ Office